Erschienen in:
24.10.2018 | Current Management of Fungal Infections (J Maertens, Section Editor)
Cryptococcosis in Patients with Hematologic Diseases
verfasst von:
Mariana Guarana, Jose Ernesto Vidal, Marcio Nucci
Erschienen in:
Current Fungal Infection Reports
|
Ausgabe 4/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
In this paper, we reviewed the epidemiology, diagnosis, and treatment of cryptococcosis in patients with hematologic malignancies. We reviewed all case series of cryptococcosis in different hematologic conditions, and looked at epidemiologic trends considering the new antineoplastic drugs introduced in the treatment of hematologic malignancies.
Recent Findings
Case series of cryptococcosis in patients with hematologic malignancies are scarce. We identified an increase in the proportion of cases of cryptococcosis occurring in patients with hematologic malignancies, and many case reports of cryptococcosis in patients receiving ibrutinib, a Bruton kinase inhibitor used in the treatment of chronic lymphoproliferative diseases.
Summary
Cryptococcosis is uncommon in patients with hematologic malignancies, but its occurrence may be associated with poor outcome. Hematologists should be aware of this complication if patients develop neurologic symptoms or present with pulmonary infiltrates that do not improve with antibiotics.